Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lutein and Reduced Oxidized Low-Density Lipoprotein Level

Doses used in studies

mg/day: 10 (median 10, IQR 10–10) — 1 study

Time to effect

Median: 6 months · IQR 6 months–6 months · Range 6 months–6 months — Reported in 1 of 1 study

1 of 1 paper

Lutein, zeaxanthin, and meso-zeaxanthin supplementation attenuates inflammatory cytokines and markers of oxidative cardiovascular processes in humans.
- 2024-05-14
- RCT
- Nutrition, metabolism, and cardiovascular diseases : NMCD 34(8)
- - Nicole T Stringham
  - Marina Green
  - Warren Roche
  - Alfonso Prado-Cabrero
  - Riona Mulcahy
  - John Nolan
- PubMed: 38890092
- DOI: 10.1016/j.numecd.2024.05.009
4 Insights on
- Reduced Oxidized Low-Density Lipoprotein Level
- High evidence
a corresponding reduction in serum OxLDL (p = 0.009)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
10 mg